Dupont Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Dupont Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-26,305	Closed	-$429K	–	1466
2020 Q3	$429K	Sell	26,305 -1,762	-6%	-$31.9K	0.01%	821
2020 Q2	$380K	Sell	28,067 -12,330	-31%	-$143K	0.01%	888
2020 Q1	$479K	Buy	40,397 +4,179	+12%	+$92.7K	0.01%	685
2019 Q4	$902K	Buy	+36,218	New	+$734K	0.02%	606
2015 Q4	–	Sell	-21,020	Closed	-$492K	–	697
2015 Q3	$492K	Hold	21,020	–	–	0.01%	539
2015 Q2	$602K	Sell	21,020 -1,550	-7%	-$40.6K	0.01%	492
2015 Q1	$583K	Hold	22,570	–	–	0.01%	496
2014 Q4	$419K	Buy	+22,570	New	+$406K	0.01%	561

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dupont Capital Management's XENT Position: Q4 2020 in Review

Dupont Capital Management sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 26,305 shares — an estimated $429K sold.

Dupont Capital Management first reported a position in XENT in Q4 2014 and held it in 8 quarters. The position peaked at $902K in Q4 2019. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

Dupont Capital Management reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
Dupont Capital Management sold 26,305 Intersect ENT, Inc shares in Q4 2020, an estimated $429K.
Dupont Capital Management first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 8 quarters.
Dupont Capital Management's Intersect ENT, Inc position peaked at $902K in Q4 2019.
110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.